Search Results

The product title you are looking for is no longer available. Other similar products that may interest you are listed below:

	Results for 'Vascular Targeting and Anti-angiogenesis in Oncology'

Title	Publication Date	Price	Relevance
Vascular Targeting and Anti-angiogenesis in Oncology Pipeline Update 2010	January 2010	£1345	99 %
Analytical Tool - Competitive Outlook on Anti-Angiogenesis and Vascular Targeting in Oncology	January 2010	£2780	95 %
Competitor Analysis VEGF and VEGF-R Agonists and Antagonists	September 2009	£540	35 %
Competitive Outlook on Antiangiogenesis and Vascular Targeting in Oncology	October 2006	£1745	35 %
Triple Analysis: Apoptosis Agents, Protein Kinase Inhibitors and Anti-Angiogenic Agents in Oncology	December 2006	£4635	26.25 %
Triple Analysis: Non Small Cell Lung Cancer, Protein Kinase Inhibitors & Anti-Angiogenic Agents	October 2006	£3090	23.8 %
Targeted Therapies in Oncology A World Review	December 2006	£4435	20.3 %
Breast Cancer Drug Pipeline Update 2009	January 2009	£1345	13.5 %
Angiogenesis in Oncology Drug Pipeline Update 2009	January 2009	£1345	13.5 %
Drug Delivery in Cancer Technologies, Markets and Companies	March 2010	£2310	8.4 %
Pipeline Insight: Hematological Malignancies Companies target niche indications to facilitate market entry	April 2009	£3965	7.7 %

Results for 'Vascular Targeting and Anti-angiogenesis in Oncology'